In Memoriam
Pure Red Cell Aplasia and Thymoma
Cytokine Gene Therapy for Malignant Pleural Mesothelioma
Lung Cancer in HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy
Does Intensive Follow-up Alter Outcome in Patients with Advanced Lung Cancer?
Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases
A Phase II Study of Concurrent Carboplatin and Paclitaxel and Thoracic Radiotherapy for Completely Resected Stage II and IIIA Non-small Cell Lung Cancer
Influence of Apoptosis and Cell Cycle Regulator Proteins on Chemotherapy Response and Survival in Stage IIIA/IIIB NSCLC Patients
Phase II Study of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), and Celecoxib, a Cyclooxygenase-2 (COX-2) Inhibitor, in Patients with Platinum Refractory Non-small Cell Lung Cancer (NSCLC)
A Randomized Phase II Trial of Two Schedules of Docetaxel in Elderly or Poor Performance Status Patients with Advanced Non-small Cell Lung Cancer
Phase II Trial with Carboplatin and Bendamustine in Patients with Extensive Stage Small-Cell Lung Cancer
Phase II Trial of Pralatrexate (10-Propargyl-10-deazaaminopterin, PDX) in Patients with Unresectable Malignant Pleural Mesothelioma
The Effect of Gefitinib on B-RAF Mutant Non-small Cell Lung Cancer and Transfectants
Thymoma with Paraneoplastic Syndromes, Good's Syndrome, and Pure Red Cell Aplasia
A Translational View of the Molecular Pathogenesis of Lung Cancer
Pulmonary Blastoma with Renal Metastasis Responds to Sorafenib
Chemotherapy for Relapsed Small Cell Lung Cancer: A Systematic Review and Practice Guideline
Supermediastinoscopies: A Step Forward in Lung Cancer Staging
European Trends in Preoperative and Intraoperative Nodal Staging: ESTS Guidelines
Mediastinoscopic Ultrasonography
Remediastinoscopy
Video-Assisted Mediastinoscopic Lymphadenectomy (VAMLA)
Transcervical Extended Mediastinal Lymphadenectomy: Results of Staging in Two Hundred Fifty-Six Patients with Non-Small Cell Lung Cancer
Efficacy of Vinorelbine in the Second-Line Setting and Beyond in Non-small Cell Lung Cancer
Meeting Announcements